[Steroid receptors and breast cancer therapy (author's transl)]. 1978

S Pavicić, and B Vujasinović, and J Borcić-Komarek, and V Kozumplik, and M Seremet, and T Popović, and S Gamulin

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Pavicić, and B Vujasinović, and J Borcić-Komarek, and V Kozumplik, and M Seremet, and T Popović, and S Gamulin
January 1980, Horumon to rinsho. Clinical endocrinology,
S Pavicić, and B Vujasinović, and J Borcić-Komarek, and V Kozumplik, and M Seremet, and T Popović, and S Gamulin
January 1981, Seikagaku. The Journal of Japanese Biochemical Society,
S Pavicić, and B Vujasinović, and J Borcić-Komarek, and V Kozumplik, and M Seremet, and T Popović, and S Gamulin
September 1981, Medicina clinica,
S Pavicić, and B Vujasinović, and J Borcić-Komarek, and V Kozumplik, and M Seremet, and T Popović, and S Gamulin
April 1981, Horumon to rinsho. Clinical endocrinology,
S Pavicić, and B Vujasinović, and J Borcić-Komarek, and V Kozumplik, and M Seremet, and T Popović, and S Gamulin
January 1978, Jugoslavenska ginekologija i opstetricija,
S Pavicić, and B Vujasinović, and J Borcić-Komarek, and V Kozumplik, and M Seremet, and T Popović, and S Gamulin
April 1980, Hospital practice,
S Pavicić, and B Vujasinović, and J Borcić-Komarek, and V Kozumplik, and M Seremet, and T Popović, and S Gamulin
June 1979, Quaderni Sclavo di diagnostica clinica e di laboratorio,
S Pavicić, and B Vujasinović, and J Borcić-Komarek, and V Kozumplik, and M Seremet, and T Popović, and S Gamulin
August 1981, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
S Pavicić, and B Vujasinović, and J Borcić-Komarek, and V Kozumplik, and M Seremet, and T Popović, and S Gamulin
October 1979, Horumon to rinsho. Clinical endocrinology,
S Pavicić, and B Vujasinović, and J Borcić-Komarek, and V Kozumplik, and M Seremet, and T Popović, and S Gamulin
January 1981, Annales d'endocrinologie,
Copied contents to your clipboard!